456 related articles for article (PubMed ID: 30212590)
1. Impact of human sepsis on CCCTC-binding factor associated monocyte transcriptional response of Major Histocompatibility Complex II components.
Siegler BH; Uhle F; Lichtenstern C; Arens C; Bartkuhn M; Weigand MA; Weiterer S
PLoS One; 2018; 13(9):e0204168. PubMed ID: 30212590
[TBL] [Abstract][Full Text] [Related]
2. Postoperative abdominal sepsis induces selective and persistent changes in CTCF binding within the MHC-II region of human monocytes.
Siegler BH; Altvater M; Thon JN; Neuhaus C; Arens C; Uhle F; Lichtenstern C; Weigand MA; Weiterer S
PLoS One; 2021; 16(5):e0250818. PubMed ID: 33939725
[TBL] [Abstract][Full Text] [Related]
3. Abdominal surgery induces long-lasting changes in expression and binding of CTCF with impact on Major Histocompatibility Complex II transcription in circulating human monocytes.
Siegler BH; Thon JN; Altvater M; Schenz J; Larmann J; Weigand MA; Weiterer S
PLoS One; 2023; 18(10):e0293347. PubMed ID: 37878653
[TBL] [Abstract][Full Text] [Related]
4. The insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactions.
Majumder P; Gomez JA; Chadwick BP; Boss JM
J Exp Med; 2008 Apr; 205(4):785-98. PubMed ID: 18347100
[TBL] [Abstract][Full Text] [Related]
5. Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients.
Pachot A; Monneret G; Brion A; Venet F; Bohé J; Bienvenu J; Mougin B; Lepape A
Crit Care Med; 2005 Jan; 33(1):31-8; discussion 236-7. PubMed ID: 15644645
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
7. CTCF controls expression and chromatin architecture of the human major histocompatibility complex class II locus.
Majumder P; Boss JM
Mol Cell Biol; 2010 Sep; 30(17):4211-23. PubMed ID: 20584980
[TBL] [Abstract][Full Text] [Related]
8. MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity.
Benasciutti E; Mariani E; Oliva L; Scolari M; Perilli E; Barras E; Milan E; Orfanelli U; Fazzalari NL; Campana L; Capobianco A; Otten L; Particelli F; Acha-Orbea H; Baruffaldi F; Faccio R; Sitia R; Reith W; Cenci S
J Bone Miner Res; 2014 Feb; 29(2):290-303. PubMed ID: 24038328
[TBL] [Abstract][Full Text] [Related]
9. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
[TBL] [Abstract][Full Text] [Related]
11. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD
Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.
Ghorpade DS; Holla S; Sinha AY; Alagesan SK; Balaji KN
J Biol Chem; 2013 Jul; 288(28):20592-606. PubMed ID: 23733190
[TBL] [Abstract][Full Text] [Related]
13. The human major histocompatibility complex class II HLA-DRB1 and HLA-DQA1 genes are separated by a CTCF-binding enhancer-blocking element.
Majumder P; Gomez JA; Boss JM
J Biol Chem; 2006 Jul; 281(27):18435-43. PubMed ID: 16675454
[TBL] [Abstract][Full Text] [Related]
14. Cis-element dependence and occupancy of the human invariant chain promoter in CIITA-dependent and -independent transcription.
Tai AK; Zhou G; Chau K; Ono SJ
Mol Immunol; 1999 May; 36(7):447-60. PubMed ID: 10449097
[TBL] [Abstract][Full Text] [Related]
15. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
Brown PJ; Wong KK; Felce SL; Lyne L; Spearman H; Soilleux EJ; Pedersen LM; Møller MB; Green TM; Gascoyne DM; Banham AH
Leukemia; 2016 Mar; 30(3):605-16. PubMed ID: 26500140
[TBL] [Abstract][Full Text] [Related]
16. The Murine MHC Class II Super Enhancer
Majumder P; Lee JT; Barwick BG; Patterson DG; Bally APR; Scharer CD; Boss JM
J Immunol; 2021 May; 206(9):2221-2232. PubMed ID: 33863790
[TBL] [Abstract][Full Text] [Related]
17. Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.
Sandhu PK; Buchkovich NJ
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915281
[TBL] [Abstract][Full Text] [Related]
18. Highly efficient peptide binding and T cell activation by MHC class II molecules of CIITA-transfected cells.
Martinez-Soria E; Siegrist CA; Mach B
Int Immunol; 1996 Apr; 8(4):543-9. PubMed ID: 8671641
[TBL] [Abstract][Full Text] [Related]
19.
Velásquez LN; Milillo MA; Delpino MV; Trotta A; Fernández P; Pozner RG; Lang R; Balboa L; Giambartolomei GH; Barrionuevo P
J Leukoc Biol; 2017 Mar; 101(3):759-773. PubMed ID: 27765819
[No Abstract] [Full Text] [Related]
20. Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis.
Waldburger JM; Palmer G; Seemayer C; Lamacchia C; Finckh A; Christofilopoulos P; Baeten D; Reith W; Gabay C
Arthritis Rheum; 2011 Nov; 63(11):3354-63. PubMed ID: 21739421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
